Fulgent Genetics financial statements

펄젠트 제네틱스NASDAQ:FLGT · Nasdaq · Healthcare · sector #17
$20.58-8.33%
2026-10-06 close

Fulgent Genetics's published financial data is dated 2026-10-04. 2024 revenue was $283M. 2024 operating profit was −$84M.

Reported results

Fulgent Genetics notifications

Quantus Signal · live data · not investment advice · Privacy Policy